SC
VERA icon

SummitTX Capital’s Vera Therapeutics VERA Stock Holding History

SummitTX Capital’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,244
Closed -$814K – 1033
2026
Q1 		$814K Buy
+20,244
New +$872K 0.03% 488
2025
Q4 		– Sell
-87,653
Closed -$2.55M – 976
2025
Q3 		$2.55M Hold
87,653
– – 0.11% 206
2025
Q2 		$2.07M Sell
87,653
-40,926
-32% -$920K 0.09% 248
2025
Q1 		$3.09M Buy
+128,579
New +$4.13M 0.13% 185

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SummitTX Capital's VERA Position: Q2 2026 in Review

SummitTX Capital sold out of Vera Therapeutics (VERA) in Q2 2026, closing a stake of 20,244 shares — an estimated $814K sold.

SummitTX Capital first reported a position in VERA in Q1 2025 and held it in 4 quarters. The position peaked at $3.09M in Q1 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • SummitTX Capital reported no remaining Vera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • SummitTX Capital sold 20,244 Vera Therapeutics shares in Q2 2026, an estimated $814K.
  • SummitTX Capital first reported a position in Vera Therapeutics in Q1 2025 and held it in 4 quarters.
  • SummitTX Capital's Vera Therapeutics position peaked at $3.09M in Q1 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.